膀胱癌检测套件的全球市场：趋势、预测和竞争分析（~2030 年）

膀胱癌检测试剂套件的趋势与预测

2030年，全球膀胱癌检测套件市场规模预计将达4亿美元，2024年至2030年复合年增长率为11.8%。市场的主要驱动因素是膀胱癌盛行率的增加、医疗保健成本的上升以及烟草消费量的增加。由于医院/诊所和诊断中心市场的机会，全球膀胱癌检测套件市场的未来前景看好。

膀胱癌检测套件市场洞察

Lucintel 预计萤光原位杂合反应在预测期内仍将是最大的细分市场。在该领域使用的新尿液检查技术使用直接标记的萤光DNA 探针来寻找尿路上皮细胞（包括尿液）的遗传异常。

由于全球医院基础设施的进步，医院和诊所将继续成为市场的最大部分。

由于该地区膀胱癌发生率不断上升，北美在预测期内仍将是最大的地区。

常问问题

Q1.市场规模有多大？

A1. 到2030年，全球膀胱癌检测套件市场预计将达到4亿美元。

Q2.市场成长预测如何？

A2. 2024年至2030年，全球膀胱癌检测套件市场预计复合年增长率为11.8%。

Q3.影响市场成长的主要驱动因素有哪些？

A3. 市场的主要驱动力是膀胱癌盛行率的增加、医疗保健成本的上升以及烟草消费量的增加。

Q4.市场的主要细分市场是什么？

A4. 由于医院和诊所市场以及诊断中心市场的机会，膀胱癌检测试剂套件市场的未来性广阔。

Q5.市场上主要企业有哪些？

A5.主要膀胱癌检测套件公司如下。

• Abbott Laboratories
• Xiamen Biotime Biotechnology
• Abingdon Health
• Ameritek
• Alfa Scientific Designs
• NanoEnTek
• Exact Sciences
• Hubei Jinjian Biology
• Nanjing Liming Bio-Products
• Diagnosis

Q6.未来最大的细分市场是什么？

A6.Lucintel表示，萤光原位杂合反应是该领域使用的一种新的尿液检查技术，利用直接标记的萤光DNA探针来检查尿路上皮细胞（包括尿液）的遗传异常。我们预计它在预测期内仍将是最大的细分市场。

Q7. 未来五年预计哪个地区将成为最大的市场？

A7. 随着膀胱癌发生率的增加，北美在预测期内仍是最大的地区。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 允许 10% 的定制，无需额外费用。

目录

第一章执行摘要

第二章全球膀胱癌检测套件市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势与预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球膀胱癌检测套件市场趋势（2018-2023）与预测（2024-2030）
• 全球膀胱癌检测套件市场：依技术分类
  • 萤光原位杂合反应
  • 酵素结合免疫吸附检测法
  • 其他的
• 全球膀胱癌检测套件市场：依最终用途产业
  • 医院/诊所
  • 诊断中心
  • 其他的

第四章市场趋势与预测分析：按地区（2018-2030）

• 全球膀胱癌检测套件市场：按地区
• 北美洲
• 欧洲
• 亚太地区
• 其他地区

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 依技术
  • 按最终用途行业
  • 按地区
• 全球膀胱癌检测套件市场新趋势
• 战略分析
  • 新产品开发
  • 全球膀胱癌检测套件市场产能扩张
  • 全球膀胱癌检测套件市场的合併、收购和合资企业
  • 认证和许可

第七章主要企业概况

• Abbott Laboratories
• Xiamen Biotime Biotechnology
• Abingdon Health
• Ameritek
• Alfa Scientific Designs
• NanoEnTek
• Exact Sciences
• Hubei Jinjian Biology
• Nanjing Liming Bio-products
• Diagnosis

Bladder Cancer Detective Kit Trends and Forecast

The future of the global bladder cancer detective kit market looks promising with opportunities in the hospitals & clinics and diagnostic centers markets. The global bladder cancer detective kit market is expected to reach an estimated $0.4 billion by 2030 with a CAGR of 11.8% from 2024 to 2030. The major drivers for this market are increasing prevalence of bladder cancer, escalating healthcare expenses, and the growing consumption of cigarettes and tobacco.

A more than 150-page report is developed to help in your business decisions.

Bladder Cancer Detective Kit by Segment

The study includes a forecast for the global bladder cancer detective kit by technology, end use industry, and region.

Bladder Cancer Detective Kit Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Fluorescence In Situ Hybridization
• Enzyme-Linked Immunosorbent Assay
• Others

Bladder Cancer Detective Kit Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Diagnostic Centers
• Others

Bladder Cancer Detective Kit Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Bladder Cancer Detective Kit Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bladder cancer detective kit companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bladder cancer detective kit companies profiled in this report include-

• Abbott Laboratories
• Xiamen Biotime Biotechnology
• Abingdon Health
• Ameritek
• Alfa Scientific Designs
• NanoEnTek
• Exact Sciences
• Hubei Jinjian Biology
• Nanjing Liming Bio-Products
• Diagnosis

Bladder Cancer Detective Kit Market Insights

Lucintel forecasts that fluorescence in situ hybridization will remain the largest segment over the forecast period due to novel urine testing technique used in this field looks for genetic abnormalities in pee-containing urothelial cells by using fluorescent DNA probes that have been directly labeled.

Within this market, hospitals & clinics will remain the largest segment due to advancements in hospital infrastructure worldwide.

North America will remain the largest region over the forecast period due to growing incidence of bladder cancer in the area.

Features of the Global Bladder Cancer Detective Kit Market

Market Size Estimates: Bladder cancer detective kit market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Bladder cancer detective kit market size by technology, end use industry, and region in terms of value ($B).

Regional Analysis: Bladder cancer detective kit market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technology, end use industry, and regions for the bladder cancer detective kit market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bladder cancer detective kit market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the bladder cancer detective kit market size?

Answer: The global bladder cancer detective kit market is expected to reach an estimated $0.4 billion by 2030.

Q2. What is the growth forecast for bladder cancer detective kit market?

Answer: The global bladder cancer detective kit market is expected to grow with a CAGR of 11.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the bladder cancer detective kit market?

Answer: The major drivers for this market are increasing prevalence of bladder cancer, escalating healthcare expenses, and the growing consumption of cigarettes and tobacco.

Q4. What are the major segments for bladder cancer detective kit market?

Answer: The future of the bladder cancer detective kit market looks promising with opportunities in the hospitals & clinics and diagnostic centers markets.

Q5. Who are the key bladder cancer detective kit market companies?

Answer: Some of the key bladder cancer detective kit companies are as follows.

• Abbott Laboratories
• Xiamen Biotime Biotechnology
• Abingdon Health
• Ameritek
• Alfa Scientific Designs
• NanoEnTek
• Exact Sciences
• Hubei Jinjian Biology
• Nanjing Liming Bio-Products
• Diagnosis

Q6. Which bladder cancer detective kit market segment will be the largest in future?

Answer: Lucintel forecasts that fluorescence in situ hybridization will remain the largest segment over the forecast period due to novel urine testing technique used in this field looks for genetic abnormalities in pee-containing urothelial cells by using fluorescent DNA probes that have been directly labeled.

Q7. In bladder cancer detective kit market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing incidence of bladder cancer in the area.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the bladder cancer detective kit market by technology (fluorescence in situ hybridization, enzyme-linked immunosorbent assay, and others), end use industry (hospitals & clinics, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bladder Cancer Detective Kit Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Bladder Cancer Detective Kit Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Bladder Cancer Detective Kit Market by Technology
  • 3.3.1: Fluorescence In Situ Hybridization
  • 3.3.2: Enzyme-Linked Immunosorbent Assay
  • 3.3.3: Others
• 3.4: Global Bladder Cancer Detective Kit Market by End Use Industry
  • 3.4.1: Hospitals & Clinics
  • 3.4.2: Diagnostic Centers
  • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Bladder Cancer Detective Kit Market by Region
• 4.2: North American Bladder Cancer Detective Kit Market
  • 4.2.2: North American Bladder Cancer Detective Kit Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, and Others
• 4.3: European Bladder Cancer Detective Kit Market
  • 4.3.1: European Bladder Cancer Detective Kit Market by Technology: Fluorescence In Situ Hybridization, Enzyme-Linked Immunosorbent Assay, and Others
  • 4.3.2: European Bladder Cancer Detective Kit Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, and Others
• 4.4: APAC Bladder Cancer Detective Kit Market
  • 4.4.1: APAC Bladder Cancer Detective Kit Market by Technology: Fluorescence In Situ Hybridization, Enzyme-Linked Immunosorbent Assay, and Others
  • 4.4.2: APAC Bladder Cancer Detective Kit Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, and Others
• 4.5: ROW Bladder Cancer Detective Kit Market
  • 4.5.1: ROW Bladder Cancer Detective Kit Market by Technology: Fluorescence In Situ Hybridization, Enzyme-Linked Immunosorbent Assay, and Others
  • 4.5.2: ROW Bladder Cancer Detective Kit Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Bladder Cancer Detective Kit Market by Technology
  • 6.1.2: Growth Opportunities for the Global Bladder Cancer Detective Kit Market by End Use Industry
  • 6.1.3: Growth Opportunities for the Global Bladder Cancer Detective Kit Market by Region
• 6.2: Emerging Trends in the Global Bladder Cancer Detective Kit Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Bladder Cancer Detective Kit Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bladder Cancer Detective Kit Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott Laboratories
• 7.2: Xiamen Biotime Biotechnology
• 7.3: Abingdon Health
• 7.4: Ameritek
• 7.5: Alfa Scientific Designs
• 7.6: NanoEnTek
• 7.7: Exact Sciences
• 7.8: Hubei Jinjian Biology
• 7.9: Nanjing Liming Bio-products
• 7.10: Diagnosis